Neuromodulation Devices Market Report 2024-2034: Surging Demand for Deep Brain Stimulation (DBS) in Neuromodulation
February 12, 2024 04:37 ET
|
Research and Markets
Dublin, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The "Neuromodulation Devices Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.Revenue for the neuromodulation devices market is...
FDA Clears Magstim Transcranial Magnetic Stimulation System Horizon 3.0 with StimGuide Pro
January 30, 2024 09:18 ET
|
Magstim EGI
FDA clears Magstim TMS System Horizon 3.0 with StimGuide Pro providing treatment for patients patients with depressive or obsessive-compulsive conditions
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
January 18, 2024 08:00 ET
|
Curonix LLC
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
Global Neuromodulation Devices Markets, 2021-2027 with 2023 as the Base Year - Future Growth Potential Enhanced by Expanding Clinical Indications and Technological Advancements
October 13, 2023 06:13 ET
|
Research and Markets
Dublin, Oct. 13, 2023 (GLOBE NEWSWIRE) -- The "Global Neuromodulation Devices Market, Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.This research service analyzes the...
Global Neuromodulation Strategic Research Report 2023: Market to Reach $11.6 Billion by 2030 - Growing Incidence of Neurodegenerative Diseases Propels the Market for Deep Brain Stimulation Devices
September 29, 2023 04:13 ET
|
Research and Markets
Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Neuromodulation - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Neuromodulation Market to Reach...
Neuromodulation Market is estimated to be US$ 12.23 billion by 2030 with a CAGR of 8.9% during the forecast period – By PMI
September 28, 2023 13:00 ET
|
PMI
Covina, Sept. 28, 2023 (GLOBE NEWSWIRE) -- What is Neuromodulation? Neuromodulation is an intracranial, electrical neuromodulation therapy that has FDA approval for the treatment for most of...
Synapse Dental Completes Equity Financing Round with Backing From AAO Innovation & Transformation Fund
September 22, 2023 08:00 ET
|
Synapse Dental
CRANSTON, R.I., Sept. 22, 2023 (GLOBE NEWSWIRE) -- Synapse Dental, the maker of the Dental Pain EraserTM, announced the completion of its first outside equity financing with backing from the...
STIMVIA Unveils Innovative Solution to Transform CNS Disorder Treatments at TechCrunch Disrupt 2023
September 20, 2023 12:00 ET
|
STIMVIA s.r.o.
SAN FRANCISCO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- STIMVIA, a pioneer medical technology company, introduces an effective non-invasive neuromodulation treatment, URIS®, addressing deep brain...
PathMaker Neurosystems Announces Initiation of First-in-Human Trial in ALS for Non-Invasive Neuromodulation Device
September 14, 2023 06:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
Brain Implants Market to hit USD 10 billion by 2032, says Global Market Insights Inc.
September 10, 2023 19:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Sept. 10, 2023 (GLOBE NEWSWIRE) -- Brain Implants Market size is expected to be worth USD 10 billion by 2032. The growing burden of neurological disorders along with the...